Lupin Shares End 3% Higher on USFDA Nod for Schizophrenia, Bipolar Disorder Drug
Shares of Lupin Ltd ended 3% higher after hitting a day’s high of Rs 1,953.80 on 3rd September, following the company’s announcement that it has...
Tag : schizophrenia
Neuland Laboratories Shares Gain Over 8% After USFDA Approval for BMS Schizophrenia Drug
Shares of Neuland Laboratories Ltd. rallied over 8% to reach a day’s high of Rs 13,630.00 on 27th September, following the USFDA approval of Bristol...
Orchid Pharma receives approval for schizophrenia drug from USFDA
Orchid Pharma receives approval for Aripiprazole Orally-Disintegrating tablets from the US health regulator. The company in a filing to BSE stated it, “has received ANDA (abbreviated...
Cadila receives USFDA approval for drug that treats schizophrenia
Cadila Healthcare’s subsidiary, has received approval from the US health regulator for Clozapine tablets, which is used to treat schizophrenia. In a filing the company stated,...
Unichem Lab has received USFDA approval for schizophrenia
The US health regulator USFDA has given its approval to Unichem Laboratories for its generic Quetiapine Fumarate tablets that are used in the treatment of...